Outcomes Among Black and Non-Hispanic White Men With mCRPC Treated With First-Line Abiraterone
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Outcomes Among African American and Non-Hispanic White Men With Metastatic Castration-Resistant Prostate Cancer With First-Line Abiraterone
JAMA Netw Open 2022 Jan 04;5(1)e2142093, M Marar, Q Long, R Mamtani, V Narayan, N Vapiwala, RB ParikhFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.